Buchert R - Search Results

1

CT-based attenuation correction in I-123-ioflupane SPECT.

Lange C, Seese A, Schwarzenböck S, Steinhoff K, Umland-Seidler B, Krause BJ, Brenner W, Sabri O, Kurth J, Hesse S, Buchert R. Lange C, et al. Among authors: buchert r. PLoS One. 2014 Sep 30;9(9):e108328. doi: 10.1371/journal.pone.0108328. eCollection 2014. PLoS One. 2014. PMID: 25268228 Free PMC article.

2

Effect of attenuation correction on lesion detectability in FDG PET of breast cancer.

Bleckmann C, Dose J, Bohuslavizki KH, Buchert R, Klutmann S, Mester J, Jänicke F, Clausen M. Bleckmann C, et al. Among authors: buchert r. J Nucl Med. 1999 Dec;40(12):2021-4. J Nucl Med. 1999. PMID: 10616880 Free article.

3

Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer's disease.

Buchert R, Wilke F, Chakrabarti B, Martin B, Brenner W, Mester J, Clausen M. Buchert R, et al. J Neuroimaging. 2005 Oct;15(4):348-55. doi: 10.1177/1051228405280169. J Neuroimaging. 2005. PMID: 16254400

4

Is correction for age necessary in SPECT or PET of the central serotonin transporter in young, healthy adults?

Buchert R, Schulze O, Wilke F, Berding G, Thomasius R, Petersen K, Brenner W, Clausen M. Buchert R, et al. J Nucl Med. 2006 Jan;47(1):38-42. J Nucl Med. 2006. PMID: 16391185 Free article. Clinical Trial.

5

Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours.

Brenner W, Friedrich RE, Gawad KA, Hagel C, von Deimling A, de Wit M, Buchert R, Clausen M, Mautner VF. Brenner W, et al. Among authors: buchert r. Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32. doi: 10.1007/s00259-005-0030-1. Epub 2006 Jan 11. Eur J Nucl Med Mol Imaging. 2006. PMID: 16404595 Clinical Trial.

6

IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies.

Buchert R, Berding G, Wilke F, Martin B, von Borczyskowski D, Mester J, Brenner W, Clausen M. Buchert R, et al. Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1073-83. doi: 10.1007/s00259-006-0067-9. Epub 2006 Apr 14. Eur J Nucl Med Mol Imaging. 2006. PMID: 16614812

7

Evaluation of a new expert system for fully automated detection of the Alzheimer's dementia pattern in FDG PET.

von Borczyskowski D, Wilke F, Martin B, Brenner W, Clausen M, Mester J, Buchert R. von Borczyskowski D, et al. Among authors: buchert r. Nucl Med Commun. 2006 Sep;27(9):739-43. doi: 10.1097/01.mnm.0000230078.25609.2b. Nucl Med Commun. 2006. PMID: 16894329

8

Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?

Buchert R, Thiele F, Thomasius R, Wilke F, Petersen K, Brenner W, Mester J, Spies L, Clausen M. Buchert R, et al. J Psychopharmacol. 2007 Aug;21(6):628-34. doi: 10.1177/0269881106071975. Epub 2006 Nov 8. J Psychopharmacol. 2007. PMID: 17092972

9

Occurrence of an artifact in brain 18F-FDG PET with calculated attenuation correction.

von Borczyskowski D, Schulte U, Brenner W, Clausen M, Buchert R. von Borczyskowski D, et al. Among authors: buchert r. J Nucl Med Technol. 2006 Dec;34(4):232-4. J Nucl Med Technol. 2006. PMID: 17146113 Free article.

10

Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1.

Buchert R, von Borczyskowski D, Wilke F, Gronowsky M, Friedrich RE, Brenner W, Mester J, Clausen M, Mautner VF. Buchert R, et al. Nucl Med Commun. 2008 Jan;29(1):17-26. doi: 10.1097/MNM.0b013e3282f1bbf5. Nucl Med Commun. 2008. PMID: 18049093 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters